Science Applications Intl SAIC underwent analysis by 8 analysts in the last quarter, revealing a spectrum of viewpoints from bullish to bearish.
The following table provides a quick overview of their recent ratings, highlighting the changing sentiments over the past 30 days and comparing them to the preceding months.
Bullish | Somewhat Bullish | Indifferent | Somewhat Bearish | Bearish | |
---|---|---|---|---|---|
Total Ratings | 0 | 4 | 3 | 0 | 1 |
Last 30D | 0 | 1 | 1 | 0 | 0 |
1M Ago | 0 | 0 | 0 | 0 | 1 |
2M Ago | 0 | 3 | 1 | 0 | 0 |
3M Ago | 0 | 0 | 1 | 0 | 0 |
The 12-month price targets assessed by analysts reveal further insights, featuring an average target of $139.0, a high estimate of $157.00, and a low estimate of $103.00. Observing a downward trend, the current average is 5.44% lower than the prior average price target of $147.00.
Decoding Analyst Ratings: A Detailed Look
A clear picture of Science Applications Intl's perception among financial experts is painted with a thorough analysis of recent analyst actions. The summary below outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
Analyst | Analyst Firm | Action Taken | Rating | Current Price Target | Prior Price Target |
---|---|---|---|---|---|
Gautam Khanna | TD Cowen | Lowers | Hold | $120.00 | $155.00 |
Matthew Akers | Wells Fargo | Lowers | Overweight | $149.00 | $154.00 |
Gavin Parsons | Goldman Sachs | Lowers | Sell | $103.00 | $124.00 |
Seth Seifman | JP Morgan | Lowers | Overweight | $148.00 | $170.00 |
Matthew Akers | Wells Fargo | Raises | Overweight | $154.00 | $147.00 |
Gavin Parsons | UBS | Announces | Neutral | $134.00 | - |
Matthew Akers | Wells Fargo | Lowers | Overweight | $147.00 | $157.00 |
Matthew Akers | Wells Fargo | Raises | Equal-Weight | $157.00 | $122.00 |
Key Insights:
- Action Taken: Responding to changing market dynamics and company performance, analysts update their recommendations. Whether they 'Maintain', 'Raise', or 'Lower' their stance, it signifies their response to recent developments related to Science Applications Intl. This offers insight into analysts' perspectives on the current state of the company.
- Rating: Offering insights into predictions, analysts assign qualitative values, from 'Outperform' to 'Underperform'. These ratings convey expectations for the relative performance of Science Applications Intl compared to the broader market.
- Price Targets: Analysts gauge the dynamics of price targets, providing estimates for the future value of Science Applications Intl's stock. This comparison reveals trends in analysts' expectations over time.
To gain a panoramic view of Science Applications Intl's market performance, explore these analyst evaluations alongside essential financial indicators. Stay informed and make judicious decisions using our Ratings Table.
Stay up to date on Science Applications Intl analyst ratings.
About Science Applications Intl
Science Applications International Corp provides technical, engineering, and enterprise IT services mainly to the U.S. government. Specifically, the company offers engineering, systems integration, and information technology for large government projects and a broad range of services with an emphasis on higher-end technology services. The company's end-to-end enterprise IT offerings span the entire spectrum of customers' IT infrastructure.
Key Indicators: Science Applications Intl's Financial Health
Market Capitalization Analysis: Below industry benchmarks, the company's market capitalization reflects a smaller scale relative to peers. This could be attributed to factors such as growth expectations or operational capacity.
Positive Revenue Trend: Examining Science Applications Intl's financials over 3 months reveals a positive narrative. The company achieved a noteworthy revenue growth rate of 4.27% as of 31 October, 2024, showcasing a substantial increase in top-line earnings. As compared to competitors, the company encountered difficulties, with a growth rate lower than the average among peers in the Industrials sector.
Net Margin: Science Applications Intl's net margin is below industry averages, indicating potential challenges in maintaining strong profitability. With a net margin of 5.36%, the company may face hurdles in effective cost management.
Return on Equity (ROE): Science Applications Intl's ROE is below industry standards, pointing towards difficulties in efficiently utilizing equity capital. With an ROE of 6.55%, the company may encounter challenges in delivering satisfactory returns for shareholders.
Return on Assets (ROA): Science Applications Intl's ROA is below industry standards, pointing towards difficulties in efficiently utilizing assets. With an ROA of 2.01%, the company may encounter challenges in delivering satisfactory returns from its assets.
Debt Management: Science Applications Intl's debt-to-equity ratio is notably higher than the industry average. With a ratio of 1.46, the company relies more heavily on borrowed funds, indicating a higher level of financial risk.
Analyst Ratings: What Are They?
Benzinga tracks 150 analyst firms and reports on their stock expectations. Analysts typically arrive at their conclusions by predicting how much money a company will make in the future, usually the upcoming five years, and how risky or predictable that company's revenue streams are.
Analysts attend company conference calls and meetings, research company financial statements, and communicate with insiders to publish their ratings on stocks. Analysts typically rate each stock once per quarter or whenever the company has a major update.
In addition to their assessments, some analysts extend their insights by offering predictions for key metrics such as earnings, revenue, and growth estimates. This supplementary information provides further guidance for traders. It is crucial to recognize that, despite their specialization, analysts are human and can only provide forecasts based on their beliefs.
Breaking: Wall Street's Next Big Mover
Benzinga's #1 analyst just identified a stock poised for explosive growth. This under-the-radar company could surge 200%+ as major market shifts unfold. Click here for urgent details.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
date | ticker | name | Price Target | Upside/Downside | Recommendation | Firm |
---|
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.